Sergio Aguirre is the founder and CEO of EchoPixel, a Silicon Valley medical imaging company that turns standard CT, MRI and ultrasound scans into interactive 3D holograms doctors can grab, rotate and dissect in open space. An electrical engineer from Tecnologico de Monterrey with a graduate focus on stereoscopic imaging, he spent more than 15 years in visualization systems before founding EchoPixel in 2012. His True3D platform earned FDA clearance and has been used in congenital heart defect detection and structural heart procedures, built on his conviction that doctors should not have to solve a 3D problem with a 2D picture.
Inquis Medical is a Silicon Valley medical device company founded in 2020 by serial medtech entrepreneurs Vahid and Mojgan Saadat. Its flagship AVENTUS Precision Thrombectomy System removes blood clots from patients with pulmonary embolism (PE) and deep vein thrombosis (DVT), using proprietary TrueClot tissue-sensing technology that gives physicians real-time feedback to distinguish blood, clot, and vessel wall while minimizing blood loss through autologous blood reinfusion. Backed by $115M in total funding including a $75M Series C in January 2026, the company is scaling nationwide commercial adoption after winning FDA 510(k) clearance for PE in 2025.